NR667,/.Chamberlain,/.CEA,/.week,/.8,/. exit,/.exa
m
1. Blood, / . Flow:, / . Lungs,/.®,/.Pulmonary,/.Veins,/.®,/.Left,/.Atrium,/.®,/.Aorta,/.®,/.Body,/.Tissues,/.®,/.Vena,/.Cava
®,/.Right,/.Ventricle,/.®,/.Pulmonary,/.Arteries,/.®,/.Lungs
2. Symptoms,/.with,/.right,/.vs,/.left,/.side,/.heart,/.blockage:,/.·,/.Blockage,/.on,/.the,/.left,/.side,/.of,/.the,/.he
art,/.backs,/.up,/.and,/.causes,/.lung,/.symptoms
·,/.Blockage,/.on,/.the,/.right,/.side,/.of,/.the,/.heart,/.backs,/.up,/.and,/.causes,/.body,/.symptoms,/.(peripheral,/.edema)
3. HNC8,/.HTN,/.Guidelines:,/.Defined,/.as,/.140/9
0,/.Treatment,/.algorithm:
Less,/.than,/.60,/.years,/.old,/.-,/.140/90
>,/.60,/.years,/.old,/.-,/.Defined,/.as,/.150/90,/.(more,/.leniency,/.b/c,/.we,/.do,/.not,/.want,/.to,/.drop,/.their,/.BP,/.too,/.low)
4. What, / . hypertension, / . medication, / . should, / . someone, / . with, / . DM, / . and/or, / . CK
D, / . be, / . on?:,/.ACE,/.or,/.ARB,/.(protects,/.kidneys)
5. What, / . HTN, / . medication, / . should, / . an, / . African, / . American, / . pt, / . be, / . on?:, / . CCB
6. What,/.HTN,/.medications,/.should,/.be,/.used,/.in,/.patients,/.with,/.heart,/.failure?:, / . Carved
i-olol,/.and,/.Thiazide,/.diuretics
7. Common,/.side,/.effects,/.from,/.ACE,/.inhibitors:,/.cough,,/.angioedema
8. What,/.HTN,/.medication,/.is,/.contraindicated,/.if,/.an,/.ACE,/.inhibitor,/.caused,/.a
n-gioedema?:,/.ARB
9. What,/.HTN,/.medication,/.should,/.a,/.heart,/.failure,/.pt,/.NEVER,/.be,/.on?:,/.CC
B,/.(These,/.cause,/.the,/.heart,/.to,/."relax",/.which,/.is,/.not,/.good,/.in,/.HF,/.pts)
10. 2,/. types,/. of, / . CCBs:,/. Dihydropyridines,/.&,/.Non-dihydropyridines
11. What,/. are, / . dihydropyridine,/. CCBs,/ . used,/ . for?:, / . BP,/.control
12. Example,/.of,/.a,/.dihydropyridine,/.CCB,/.and,/.side,/.effects:,/.Amlodipine,
/.Bradycardic,/.side,/.ettects,,/.peripheral,/.edema,,/.constipation
13. What,/.are,/.non-dihydropyridine,/.CCBs,/.used,/.for?:,/.arrhythmias
14. Example,/.of,/.a,/.non-
dihydropyridine,/.CCB,/.and,/.side,/.effects:,/.cardizem,/.Tachycardic,/.side,/.ettects/palp
itations,/.-,/.these,/.meds,/.were,/.peripherally,/.and,/.have,/.a,/.rebound,/.tachycardia
15. The,/.atria,/.(top,/.chambers,/.of,/.the,/.heart),/.work,/.on,/.which,/.electrolytes?:,/.K+,/.(potas
si-um),/.and,/.Ca,/.(calcium)
, NR667,/.Chamberlain,/.CEA,/.week,/.8,/. exit,/.exa
m
16. The,/.ventricles,/.(bottom,/.chambers,/.of,/.the,/.heart),/.work,/.on,/.which,/.electrolytes?-
:, / . Na,/.(sodium),/.and,/.K+,/.(potassium)
17. Conditions,/.in,/.the,/.atria,/.needs,/.medications,/.that,/.work,/.on,/.K+,/.or,/.Ca,/.such,/.as
..:,/.Cardizem,/.(CCB),/.or,/.Amiodarone,/.(potassium,/.channel,/.blocker)
18. Conditions, / . in, / . the, / . ventricles, / . needs, / . medications, / . that, / . work, / . on, / . K+, / . or, / .
Na, / . such,/.as,/...:,/.Amiodarone,/.(potassium,/.channel,/.blocker)
19. What, / . class, / . of, / . medications, / . could, / . be, / . used, / . for, / . atrial, / . and, / . ventricular,
/ . condi-tions?:,/.Beta-blockers,/.or,/.potassium,/.channel,/.blocker,/.(Amiodarone)
20. What, / . is, / . the, / . percentage, / . of, / . EF, / . for, / . someone, / . with, / . HF, / . with, / . reduced, / . EF?:, / . <,/.4
0%
21. What,/.is,/.the,/.percentage,/.of,/.EF,/.for,/.someone,/.with,/.HF,/.with,/.preserved,/.EF?:,/.40,/.
or,/.greater
22. HF,/.patients,/.with,/.reduced,/.EF,/.need,/.to,/.be,/.on,/.what,/.medications?:,/.Carvedilol,,/.loop,/.
diuretic,,/.ACE,,/.or,/.ARB
23. What, / . type, / . of, / . diuretics, / . are, / . more, / . potent?:, / . Loop,/.diuretics
24. Which,/.hypertensive,/.medications,/.are,/."cardio-protective"?:,/.ACEs,/.and,/.ARBs
25. Functional,/. classes,/. of,/. HF, / . (NYHA)::
26. :,/.I:,/.No,/.sx
II:,/.Sx,/.w/,/.moderate,/.exertion,/
.III:,/.Sx,/.w,/.ADLs
IV:,/.Sx,/.at,/.rest
27. What,/.is,/.the,/.ASCVD,/.risk,/.score?:,/.measurement,/.of,/.a,/.pt's,/.10,/.yr,/.risk,/.of,/.an,/.adverse,/.cardiac,/.event
28. What,/.are,/.the,/.high-intensity,/.statins?:,/.Atorvastatin,/.40-
80,/.mg,/.Rosuvastatin,/.20-40,/.mg
29. What,/. happens, / . during,/. S1,/. heart, / . sounds?:,/ . mitral,/.valve,/.closes,/.and,/.aortic,/.valve,/.opens
30. Which,/.structural,/.heart,/.condition,/.can,/.cause,/.syncope,/.or,/.near-
syncope?:,/.Aortic,/.stenosis
31. Which,/.structural,/.heart,/.condition,/.cause,/.a,/.harsh,,/.high-
pitches,/.sound,/.that,/.can,/.be,/.heard,/.in,/.the,/.neck,/.or,/.on,/.the,/.right,/.side,/.of,/.the,/.ches
t,/.near,/.the,/.2nd,/.intercostal,/.space?:,/.Aortic,/.regurgitation/insuflciency
32. Which,/.structural,/.heart,/.condition,/.is,/.very,/.loud,/.and,/.can,/.be,/.heard,/.on,/.the,/.lower,
/ . left,/.side,/.of,/.the,/.chest?:,/.Mitral,/.regurgitation/insuflciency
, NR667,/.Chamberlain,/.CEA,/.week,/.8,/. exit,/.exa
m
33. What,/.are,/. the,/.2,/. most,/. common,/.places,/.for,/.a,/.AAA?:,/. infra-renal,/.and,/.ascending,/.aorta
, NR667,/.Chamberlain,/.CEA,/.week,/.8,/. exit,/.exa
m
34. Which,/.aortic,/.aneurysm,/.requires,/.surgery,/.right,/.away?:,/.Stanford,/.A,/.(ascending)
35. Which, / . aortic, / . aneurysm, / . is, / . often, / . treated, / . medically, / . or, / . with, / . a, / . possibl
e, / . graft,/.(but,/.does,/.not,/.often,/.need,/.surgery)?:,/.Stanford,/.B,/.(descending)
36. What, / . is, / . a, / . medical, / . intervention, / . that, / . should, / . be, / . done, / . for, / . a, / . patient
, / . with, / . a,/.Stanford,/.B,/.aneurysm?:,/.Keep,/.BP,/.low
37. What, / . class, / . medication, / . should, / . NEVER, / . be, / . given, / . to, / . a, / . patient, / . with, / . a
n,/.aneurysm,/.or,/.any,/.sort,/.of,/.connective,/.tissue,/.disorder?:,/.flouroquinolones,/.(end,/.in,/."floxi
cin")
38. What,/.are,/.the,/.4,/.fat-
soluble,/.vitamins?,/.(stay,/.in,/.the,/.body,/.for,/.a,/.long,/.time):,/.ADEK
39. What,/.percentage,/.of,/.pulmonary,/.emboli,/.or,/.DVTs,/.are,/.provoked?:,/.70%
40. How, / . long, / . should, / . a, / . patient, / . with, / . a, / . provoked, / . PE, / . or, / . DVT, / . be, / . treated
, / . with, / . an,/.anticoagulant?:,/.at,/.least,/.3,/.months
41. How, / . long, / . should, / . a, / . patient, / . with, / . a, / . non-
provoked, / . PE, / . or, / . DVT, / . be, / . treated, / . with,/.an,/.anticoagulant?:,/.at,/.least,/.3,/.months,,/.but,/.cou
ld,/.be,/.lifelong,/.if,/.any,/.recurrence
42. What,/.is,/.the,/.Virchow's,/.triad?:,/.3,/.broad,/.categories,/.of,/.factors,/.that,/.are,/.thought,/.to,/.contribute
,/.to,/.thrombosis
43. What,/.are,/.things,/.that,/.could,/.contribute,/.to,/.a,/.provoked,/.PE,/.or,/.DVT?:,/.Anesthesia
,,/.immobility,,/.pregnancy,,/.hypercoagulable,/.state,,/.DVT,,/.cancer,,/.hormone,/.replacement
44. What,/.are,/.the,/.3,/.things,/.that,/.make,/.up,/.the,/.Virchow's,/.triad?:,/.Venous,/.sta
sis,/.Hypercoagulability
Endothelial,/. injury
45. What, / . testing, / . should, / . be, / . done, / . first, / . to, / . look, / . for, / . peripheral, / . artery, / . disea
se?:, / . an-kle-brachial,/.index,/.(BP,/.will,/.be,/.lower,/.on,/.the,/.ankles,/.vs,/.arms)
46. What, / . test, / . will, / . confirm, / . a, / . diagnosis, / . of, / . PAD?:, / . angiography
47. Symptoms,/.of,/.PAD:,/.pale,,/.waxy,,/.hairless,/.legs
pain,/.with,/.ambulation,/.that,/.improves,/.with,/.cessation,/.of,/.ambulation
48. Treatment,/.for,/.PAD:,/.stents,/.of,/.bypass,/.of,/.vessel
s,/.Anti-platelet,/.medications
Statins,/.for,/.lipid,/.management
Lifestyle, / . modifications, / . and, / . management, / . of, / . co-morbidities, / . (diabetes)
m
1. Blood, / . Flow:, / . Lungs,/.®,/.Pulmonary,/.Veins,/.®,/.Left,/.Atrium,/.®,/.Aorta,/.®,/.Body,/.Tissues,/.®,/.Vena,/.Cava
®,/.Right,/.Ventricle,/.®,/.Pulmonary,/.Arteries,/.®,/.Lungs
2. Symptoms,/.with,/.right,/.vs,/.left,/.side,/.heart,/.blockage:,/.·,/.Blockage,/.on,/.the,/.left,/.side,/.of,/.the,/.he
art,/.backs,/.up,/.and,/.causes,/.lung,/.symptoms
·,/.Blockage,/.on,/.the,/.right,/.side,/.of,/.the,/.heart,/.backs,/.up,/.and,/.causes,/.body,/.symptoms,/.(peripheral,/.edema)
3. HNC8,/.HTN,/.Guidelines:,/.Defined,/.as,/.140/9
0,/.Treatment,/.algorithm:
Less,/.than,/.60,/.years,/.old,/.-,/.140/90
>,/.60,/.years,/.old,/.-,/.Defined,/.as,/.150/90,/.(more,/.leniency,/.b/c,/.we,/.do,/.not,/.want,/.to,/.drop,/.their,/.BP,/.too,/.low)
4. What, / . hypertension, / . medication, / . should, / . someone, / . with, / . DM, / . and/or, / . CK
D, / . be, / . on?:,/.ACE,/.or,/.ARB,/.(protects,/.kidneys)
5. What, / . HTN, / . medication, / . should, / . an, / . African, / . American, / . pt, / . be, / . on?:, / . CCB
6. What,/.HTN,/.medications,/.should,/.be,/.used,/.in,/.patients,/.with,/.heart,/.failure?:, / . Carved
i-olol,/.and,/.Thiazide,/.diuretics
7. Common,/.side,/.effects,/.from,/.ACE,/.inhibitors:,/.cough,,/.angioedema
8. What,/.HTN,/.medication,/.is,/.contraindicated,/.if,/.an,/.ACE,/.inhibitor,/.caused,/.a
n-gioedema?:,/.ARB
9. What,/.HTN,/.medication,/.should,/.a,/.heart,/.failure,/.pt,/.NEVER,/.be,/.on?:,/.CC
B,/.(These,/.cause,/.the,/.heart,/.to,/."relax",/.which,/.is,/.not,/.good,/.in,/.HF,/.pts)
10. 2,/. types,/. of, / . CCBs:,/. Dihydropyridines,/.&,/.Non-dihydropyridines
11. What,/. are, / . dihydropyridine,/. CCBs,/ . used,/ . for?:, / . BP,/.control
12. Example,/.of,/.a,/.dihydropyridine,/.CCB,/.and,/.side,/.effects:,/.Amlodipine,
/.Bradycardic,/.side,/.ettects,,/.peripheral,/.edema,,/.constipation
13. What,/.are,/.non-dihydropyridine,/.CCBs,/.used,/.for?:,/.arrhythmias
14. Example,/.of,/.a,/.non-
dihydropyridine,/.CCB,/.and,/.side,/.effects:,/.cardizem,/.Tachycardic,/.side,/.ettects/palp
itations,/.-,/.these,/.meds,/.were,/.peripherally,/.and,/.have,/.a,/.rebound,/.tachycardia
15. The,/.atria,/.(top,/.chambers,/.of,/.the,/.heart),/.work,/.on,/.which,/.electrolytes?:,/.K+,/.(potas
si-um),/.and,/.Ca,/.(calcium)
, NR667,/.Chamberlain,/.CEA,/.week,/.8,/. exit,/.exa
m
16. The,/.ventricles,/.(bottom,/.chambers,/.of,/.the,/.heart),/.work,/.on,/.which,/.electrolytes?-
:, / . Na,/.(sodium),/.and,/.K+,/.(potassium)
17. Conditions,/.in,/.the,/.atria,/.needs,/.medications,/.that,/.work,/.on,/.K+,/.or,/.Ca,/.such,/.as
..:,/.Cardizem,/.(CCB),/.or,/.Amiodarone,/.(potassium,/.channel,/.blocker)
18. Conditions, / . in, / . the, / . ventricles, / . needs, / . medications, / . that, / . work, / . on, / . K+, / . or, / .
Na, / . such,/.as,/...:,/.Amiodarone,/.(potassium,/.channel,/.blocker)
19. What, / . class, / . of, / . medications, / . could, / . be, / . used, / . for, / . atrial, / . and, / . ventricular,
/ . condi-tions?:,/.Beta-blockers,/.or,/.potassium,/.channel,/.blocker,/.(Amiodarone)
20. What, / . is, / . the, / . percentage, / . of, / . EF, / . for, / . someone, / . with, / . HF, / . with, / . reduced, / . EF?:, / . <,/.4
0%
21. What,/.is,/.the,/.percentage,/.of,/.EF,/.for,/.someone,/.with,/.HF,/.with,/.preserved,/.EF?:,/.40,/.
or,/.greater
22. HF,/.patients,/.with,/.reduced,/.EF,/.need,/.to,/.be,/.on,/.what,/.medications?:,/.Carvedilol,,/.loop,/.
diuretic,,/.ACE,,/.or,/.ARB
23. What, / . type, / . of, / . diuretics, / . are, / . more, / . potent?:, / . Loop,/.diuretics
24. Which,/.hypertensive,/.medications,/.are,/."cardio-protective"?:,/.ACEs,/.and,/.ARBs
25. Functional,/. classes,/. of,/. HF, / . (NYHA)::
26. :,/.I:,/.No,/.sx
II:,/.Sx,/.w/,/.moderate,/.exertion,/
.III:,/.Sx,/.w,/.ADLs
IV:,/.Sx,/.at,/.rest
27. What,/.is,/.the,/.ASCVD,/.risk,/.score?:,/.measurement,/.of,/.a,/.pt's,/.10,/.yr,/.risk,/.of,/.an,/.adverse,/.cardiac,/.event
28. What,/.are,/.the,/.high-intensity,/.statins?:,/.Atorvastatin,/.40-
80,/.mg,/.Rosuvastatin,/.20-40,/.mg
29. What,/. happens, / . during,/. S1,/. heart, / . sounds?:,/ . mitral,/.valve,/.closes,/.and,/.aortic,/.valve,/.opens
30. Which,/.structural,/.heart,/.condition,/.can,/.cause,/.syncope,/.or,/.near-
syncope?:,/.Aortic,/.stenosis
31. Which,/.structural,/.heart,/.condition,/.cause,/.a,/.harsh,,/.high-
pitches,/.sound,/.that,/.can,/.be,/.heard,/.in,/.the,/.neck,/.or,/.on,/.the,/.right,/.side,/.of,/.the,/.ches
t,/.near,/.the,/.2nd,/.intercostal,/.space?:,/.Aortic,/.regurgitation/insuflciency
32. Which,/.structural,/.heart,/.condition,/.is,/.very,/.loud,/.and,/.can,/.be,/.heard,/.on,/.the,/.lower,
/ . left,/.side,/.of,/.the,/.chest?:,/.Mitral,/.regurgitation/insuflciency
, NR667,/.Chamberlain,/.CEA,/.week,/.8,/. exit,/.exa
m
33. What,/.are,/. the,/.2,/. most,/. common,/.places,/.for,/.a,/.AAA?:,/. infra-renal,/.and,/.ascending,/.aorta
, NR667,/.Chamberlain,/.CEA,/.week,/.8,/. exit,/.exa
m
34. Which,/.aortic,/.aneurysm,/.requires,/.surgery,/.right,/.away?:,/.Stanford,/.A,/.(ascending)
35. Which, / . aortic, / . aneurysm, / . is, / . often, / . treated, / . medically, / . or, / . with, / . a, / . possibl
e, / . graft,/.(but,/.does,/.not,/.often,/.need,/.surgery)?:,/.Stanford,/.B,/.(descending)
36. What, / . is, / . a, / . medical, / . intervention, / . that, / . should, / . be, / . done, / . for, / . a, / . patient
, / . with, / . a,/.Stanford,/.B,/.aneurysm?:,/.Keep,/.BP,/.low
37. What, / . class, / . medication, / . should, / . NEVER, / . be, / . given, / . to, / . a, / . patient, / . with, / . a
n,/.aneurysm,/.or,/.any,/.sort,/.of,/.connective,/.tissue,/.disorder?:,/.flouroquinolones,/.(end,/.in,/."floxi
cin")
38. What,/.are,/.the,/.4,/.fat-
soluble,/.vitamins?,/.(stay,/.in,/.the,/.body,/.for,/.a,/.long,/.time):,/.ADEK
39. What,/.percentage,/.of,/.pulmonary,/.emboli,/.or,/.DVTs,/.are,/.provoked?:,/.70%
40. How, / . long, / . should, / . a, / . patient, / . with, / . a, / . provoked, / . PE, / . or, / . DVT, / . be, / . treated
, / . with, / . an,/.anticoagulant?:,/.at,/.least,/.3,/.months
41. How, / . long, / . should, / . a, / . patient, / . with, / . a, / . non-
provoked, / . PE, / . or, / . DVT, / . be, / . treated, / . with,/.an,/.anticoagulant?:,/.at,/.least,/.3,/.months,,/.but,/.cou
ld,/.be,/.lifelong,/.if,/.any,/.recurrence
42. What,/.is,/.the,/.Virchow's,/.triad?:,/.3,/.broad,/.categories,/.of,/.factors,/.that,/.are,/.thought,/.to,/.contribute
,/.to,/.thrombosis
43. What,/.are,/.things,/.that,/.could,/.contribute,/.to,/.a,/.provoked,/.PE,/.or,/.DVT?:,/.Anesthesia
,,/.immobility,,/.pregnancy,,/.hypercoagulable,/.state,,/.DVT,,/.cancer,,/.hormone,/.replacement
44. What,/.are,/.the,/.3,/.things,/.that,/.make,/.up,/.the,/.Virchow's,/.triad?:,/.Venous,/.sta
sis,/.Hypercoagulability
Endothelial,/. injury
45. What, / . testing, / . should, / . be, / . done, / . first, / . to, / . look, / . for, / . peripheral, / . artery, / . disea
se?:, / . an-kle-brachial,/.index,/.(BP,/.will,/.be,/.lower,/.on,/.the,/.ankles,/.vs,/.arms)
46. What, / . test, / . will, / . confirm, / . a, / . diagnosis, / . of, / . PAD?:, / . angiography
47. Symptoms,/.of,/.PAD:,/.pale,,/.waxy,,/.hairless,/.legs
pain,/.with,/.ambulation,/.that,/.improves,/.with,/.cessation,/.of,/.ambulation
48. Treatment,/.for,/.PAD:,/.stents,/.of,/.bypass,/.of,/.vessel
s,/.Anti-platelet,/.medications
Statins,/.for,/.lipid,/.management
Lifestyle, / . modifications, / . and, / . management, / . of, / . co-morbidities, / . (diabetes)
